Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space
Therapeutic antibody development requires selection and engineering of molecules with high affinity and other drug-like biophysical properties. Co-optimization of multiple antibody properties remains a difficult and time-consuming process that impedes drug development. Here we evaluate the use of ma...
Main Authors: | Desai, A.A (Author), Huang, J. (Author), Kinnunen, P.C (Author), Linderman, J.J (Author), Makowski, E.K (Author), Schardt, J.S (Author), Smith, M.D (Author), Streu, C.N (Author), Tessier, P.M (Author), Wang, T. (Author), Wu, L. (Author), Zhang, Y. (Author), Zupancic, J.M (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Toward Drug-Like Multispecific Antibodies by Design
by: Manali S. Sawant, et al.
Published: (2020-10-01) -
The role of somatic mutation in determining the affinity of anti-DNA antibodies.
by: Behrendt, M., et al.
Published: (2009) -
Affinity labelling of antibodies
by: Fisher, Christopher Edward
Published: (1972) -
Facile Affinity Maturation of Antibody Variable Domains Using Natural Diversity Mutagenesis
by: Kathryn E. Tiller, et al.
Published: (2017-09-01) -
Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
by: Chakraborty, A.K, et al.
Published: (2022)